Asko Riutta

1.0k total citations
52 papers, 884 citations indexed

About

Asko Riutta is a scholar working on Physiology, Pharmacology and Biochemistry. According to data from OpenAlex, Asko Riutta has authored 52 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 12 papers in Pharmacology and 12 papers in Biochemistry. Recurrent topics in Asko Riutta's work include Eicosanoids and Hypertension Pharmacology (12 papers), Inflammatory mediators and NSAID effects (12 papers) and Nitric Oxide and Endothelin Effects (9 papers). Asko Riutta is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (12 papers), Inflammatory mediators and NSAID effects (12 papers) and Nitric Oxide and Endothelin Effects (9 papers). Asko Riutta collaborates with scholars based in Finland, Hungary and United States. Asko Riutta's co-authors include Heikki Vapaatalo, Juha Alanko, T. Metsä‐Ketelä, Pauli Ylitalo, I. Muchá, Päivi Holm, Eeva Sievi, Merja Vainio, Seppo Kaukinen and Erkki Seppälä and has published in prestigious journals such as Analytical Biochemistry, Free Radical Biology and Medicine and Critical Care Medicine.

In The Last Decade

Asko Riutta

52 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asko Riutta Finland 19 189 166 115 114 109 52 884
David J. Freeman Canada 18 183 1.0× 249 1.5× 205 1.8× 152 1.3× 165 1.5× 38 2.0k
Chin‐Chen Wu Taiwan 15 256 1.4× 190 1.1× 84 0.7× 58 0.5× 102 0.9× 34 873
PP Nawroth Germany 15 344 1.8× 279 1.7× 167 1.5× 84 0.7× 116 1.1× 44 1.3k
Necat Yılmaz Türkiye 21 155 0.8× 238 1.4× 136 1.2× 90 0.8× 145 1.3× 85 1.2k
Erkki Seppälä Finland 16 273 1.4× 107 0.6× 101 0.9× 250 2.2× 157 1.4× 60 872
Serdar Öztezcan Türkiye 17 259 1.4× 249 1.5× 101 0.9× 52 0.5× 54 0.5× 30 1.0k
Konstantinos Paletas Greece 17 263 1.4× 300 1.8× 168 1.5× 54 0.5× 109 1.0× 35 1.2k
Claudie Cambon France 16 220 1.2× 428 2.6× 74 0.6× 112 1.0× 126 1.2× 24 1.1k
Beyzagül Polat Türkiye 23 169 0.9× 277 1.7× 195 1.7× 133 1.2× 84 0.8× 50 1.2k
Vishal Diwan Australia 12 297 1.6× 329 2.0× 119 1.0× 83 0.7× 91 0.8× 14 1.2k

Countries citing papers authored by Asko Riutta

Since Specialization
Citations

This map shows the geographic impact of Asko Riutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asko Riutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asko Riutta more than expected).

Fields of papers citing papers by Asko Riutta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asko Riutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asko Riutta. The network helps show where Asko Riutta may publish in the future.

Co-authorship network of co-authors of Asko Riutta

This figure shows the co-authorship network connecting the top 25 collaborators of Asko Riutta. A scholar is included among the top collaborators of Asko Riutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asko Riutta. Asko Riutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurra, Venla, Timo Paavonen, Teemu Honkanen, et al.. (2022). Moderate hyperuricaemia ameliorated kidney damage in a low‐renin model of experimental renal insufficiency. Basic & Clinical Pharmacology & Toxicology. 132(1). 21–32. 2 indexed citations
2.
Riutta, Asko, Meng Fan, Jenni Koskela, et al.. (2012). Dietary Phosphate Binding and Loading Alter Kidney Angiotensin-Converting Enzyme mRNA and Protein Content in 5/6 Nephrectomized Rats. American Journal of Nephrology. 35(5). 401–408. 18 indexed citations
3.
Natarajan, Renuka, Elísabet Einarsdóttir, Asko Riutta, et al.. (2012). Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients. Journal of Neuroimmunology. 250(1-2). 106–110. 36 indexed citations
4.
Riutta, Asko, Pauli Ylitalo, & Seppo Kaukinen. (2009). Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients. Intensive Care Medicine. 35(10). 1720–1727. 20 indexed citations
5.
Kurra, Vikram, Pasi Jolma, Asko Riutta, et al.. (2009). Hyperuricemia, Oxidative Stress, and Carotid Artery Tone in Experimental Renal Insufficiency. American Journal of Hypertension. 22(9). 964–970. 26 indexed citations
6.
Nieminen, Riina, Katriina Vuolteenaho, Asko Riutta, et al.. (2008). Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability. European Journal of Pharmacology. 587(1-3). 309–316. 20 indexed citations
7.
Huuhka, Kaija, et al.. (2006). The effect of CYP2C19 substrate on the metabolism of melatonin inthe elderly: A randomized, double blind, placebo-controlled study. Methods and Findings in Experimental and Clinical Pharmacology. 28(7). 447–447. 13 indexed citations
8.
Riutta, Asko, et al.. (2004). Revascularization decreases 8-isoprostaglandin F2α excretion in chronic lower limb ischemia. Prostaglandins Leukotrienes and Essential Fatty Acids. 71(2). 97–101. 10 indexed citations
9.
Holma, Reetta, Pertteli Salmenperä, Asko Riutta, et al.. (2001). Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. European Journal of Pharmacology. 429(1-3). 309–318. 49 indexed citations
10.
Alanko, Juha, et al.. (1999). Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant/prooxidant properties. Free Radical Biology and Medicine. 26(1-2). 193–201. 112 indexed citations
11.
Sievi, Eeva, et al.. (1999). Nicotinic Acid and Pyridoxine Modulate Arachidonic Acid Metabolism in vitro and ex vivo in Man. Pharmacology & Toxicology. 84(6). 274–280. 21 indexed citations
12.
Alanko, Juha, et al.. (1999). Amrinone, a Phosphodiesterase III Inhibitor, and Arachidonic Acid Metabolism in Humans. Journal of Cardiovascular Pharmacology. 33(1). 140–143. 2 indexed citations
13.
Sievi, Eeva, et al.. (1998). Nicotine stereoisomers and cotinine stimulate prostaglandin E2 but inhibit thromboxane B2 and leukotriene E4 synthesis in whole blood. European Journal of Pharmacology. 353(1). 87–92. 31 indexed citations
14.
15.
Riutta, Asko, et al.. (1995). Phenols inhibit prostaglandin E2 synthesis in A23187-stimulated human whole blood and modify the ratio of arachidonic acid metabolites. Prostaglandins Leukotrienes and Essential Fatty Acids. 52(5). 299–301. 2 indexed citations
16.
Riutta, Asko, et al.. (1994). Adrenaline infusion increases systemic prostacyclin production in man. Prostaglandins. 48(1). 43–51. 10 indexed citations
17.
Riutta, Asko, et al.. (1993). Nicotine and cotinine modulate eicosanoid production in human leukocytes and platelet rich plasma. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 248(4). 345–349. 19 indexed citations
18.
Alanko, Juha, et al.. (1993). Modulation of arachidonic acid metabolism by phenols: Relation to positions of hydroxyl groups and peroxyl radical scavenging properties. Free Radical Biology and Medicine. 14(1). 19–25. 45 indexed citations
19.
Riutta, Asko, et al.. (1992). Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. Analytical Biochemistry. 202(2). 299–305. 24 indexed citations
20.
Riutta, Asko, et al.. (1991). Catecholamines decrease leukotriene B4 and increase thromboxane B2 synthesis in A23187-stimulated human whole blood. Prostaglandins. 42(3). 279–287. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Freeman Breakdown of academic impact, for papers by Chin‐Chen Wu Breakdown of academic impact, for papers by PP Nawroth Breakdown of academic impact, for papers by Necat Yılmaz Breakdown of academic impact, for papers by Erkki Seppälä Breakdown of academic impact, for papers by Serdar Öztezcan Breakdown of academic impact, for papers by Konstantinos Paletas Breakdown of academic impact, for papers by Claudie Cambon Breakdown of academic impact, for papers by Beyzagül Polat Breakdown of academic impact, for papers by Vishal Diwan
Rankless by CCL
2026